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LETTER TO THE EDITOR

MicroRNA-16, Programmed
Cell Death Protein-4 (PDCD-4)
and Polycystic Ovarian
Syndrome
Sir,
Polycystic ovarian syndrome (PCOS) is a prevalent disease in
7-9% of the women of reproductive age.1 The severity of PCOS
can be determined by Rotterdam criteria, depending upon the
spectrum of characteristics present, including hyperandrogenism (H), and/or lack of ovulation (O), and/or ovarian cysts
(OC). These include category-1: H+O, category-2: O+OC, category-3: H+OC, and category-4: all 3 characteristics present. Its
reproductive disturbances manifest as menstrual irregularities,
lack of ovulation, impaired follicular maturation, hyperandrogenism, which eventually funnel to infertility. Its metabolic
disturbances, present in almost half of PCOS patients,2 include
high blood pressure, insulin resistance, obesity and abnormal
lipid proﬁle.1
Micro-RNAs have single strands and small segments of non-coding RNA (18-25 nucleotides), which break down RNA and
prevent translation by binding to 3’-UTR at post-transcriptional
level, thus are important players in cell growth and death.1,3
Studies focusing on altered serum miRNA levels in PCOS,
suggest its use as a prognostic and diagnostic marker for PCOS.2

by down regulating RNA helicase activity during translation.
MiR-16, on chromosome 13q14, is low in PCOS. Fu et al. stated
that the level of miR-16 in the ovarian cortical cells and blood
was decreased in PCOS, while ovarian cortex’s PDCD-4 level
2
was increased. Contrarily, increased miR-16 in PCOS women’
granulosa cells promoted cellular proliferation and decreased
cell death, where a greater number of cells were in the S phase
and few in GO-G1 phase, while increased PDCD-4 and
decreased miR-16 expression reversed these eﬀects. High
testosterone levels in PCOS alter folliculogenesis by decreasing
miR-16 and increasing PDCD-4, resulting in more cell death and
1
decreased cellular proliferation. Thus, it can be concluded that
the impaired follicular growth and granulosa cell death in PCOS
can be improved by increasing miR-16 expression which has an
1
eﬀect on PDCD-4 at the molecular level.
MiRNA-16 levels can then serve as a conﬁrmatory diagnostic
test for PCOS. Thus, a sensitive and speciﬁc diagnosis can be
carried out which is minimally invasive, less expensive and
comfortable for the patients, unlike transvaginal ultrasonography.2
It shows isolated eﬀects of MiRNA-16 and PDCD-4 on diﬀerent
stages of the cell cycle. Diﬀerent levels of miRNA-16 and
PDCD-4 change the balance of cells, particularly in the GO, G1
and S phase. High levels of PDCD-4 result in a positive impact
and an increase in the number of cells in the G0 and G1 phase,
while cause an opposite eﬀect on the cells in S phase, i.e. a
decrease in their number. On the other hand, increased serum
levels of MiRNA-16 have opposite eﬀects on the cells in the 3
phases. These ﬁndings agree with the ﬁndings of the cellular
proliferative and anti-apoptotic eﬀect of MiRNA-16, as fewer
cells will be in the resting stage and more will be in the DNA
replicative stage, leading to the mitotically growing stage.
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Figure 1: Diagrammatic representation of eﬀect of MiRNA-16 and PDCD-4
on cell cycle.4

The association between miR-16 and programmed cell death
protein-4 (PDCD-4) and their contributory roles in the progression of PCOS is still under analytic study. PDCD-4, present on
chromosome 10q24, increases in PCOS and induces apoptosis
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